[Line Items] for disaggregated revenue [Table]

No definition available.

Name:	bsx_DisaggregatedrevenueLineItems
Namespace Prefix:	bsx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of revenue recognized that was previously reported as deferred or unearned revenue.

+ References

+ Details

Name:	us-gaap_DeferredRevenueRevenueRecognized1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_StatementGeographicalAxis=bsx_EmergingMarketsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_EMEAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_AsiaPacificMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=bsx_LatinAmericaandCanadaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_EndoscopyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_UrologyandPelvicHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_ElectrophysiologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_NeuromodulationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_InterventionalCardiologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=bsx_PeripheralInterventionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue Revenue Disclosure (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Jan. 01, 2018
disaggregated revenue [Line Items]
Revenue, Net	$ 2,379	$ 2,160
Deferred Revenue	393		$ 411
Deferred Revenue, Revenue Recognized	26
Emerging Markets [Member]
disaggregated revenue [Line Items]
Revenue, Net	255	208
UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	1,310	1,249
Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	1,069	911
EMEA [Member]
disaggregated revenue [Line Items]
Revenue, Net	563	454
Asia Pacific [Member]
disaggregated revenue [Line Items]
Revenue, Net	415	371
Latin America and Canada [Member]
disaggregated revenue [Line Items]
Revenue, Net	91	84
Endoscopy [Member]
disaggregated revenue [Line Items]
Revenue, Net	418	379
Endoscopy [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	231	215
Endoscopy [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	187	164
Urology and Pelvic Health [Member]
disaggregated revenue [Line Items]
Revenue, Net	293	262
Urology and Pelvic Health [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	197	183
Urology and Pelvic Health [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	96	79
Cardiac Rhythm Management [Member]
disaggregated revenue [Line Items]
Revenue, Net	493	463
Cardiac Rhythm Management [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	290	283
Cardiac Rhythm Management [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	203	180
Electrophysiology [Member]
disaggregated revenue [Line Items]
Revenue, Net	75	64
Electrophysiology [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	35	32
Electrophysiology [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	39	32
Neuromodulation [Member]
disaggregated revenue [Line Items]
Revenue, Net	169	141
Neuromodulation [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	131	116
Neuromodulation [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	38	25
Interventional Cardiology [Member]
disaggregated revenue [Line Items]
Revenue, Net	645	590
Interventional Cardiology [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	281	278
Interventional Cardiology [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	364	312
Peripheral Interventions [Member]
disaggregated revenue [Line Items]
Revenue, Net	288	261
Peripheral Interventions [Member] \| UNITED STATES
disaggregated revenue [Line Items]
Revenue, Net	145	142
Peripheral Interventions [Member] \| Non-US [Member]
disaggregated revenue [Line Items]
Revenue, Net	$ 142	$ 119